Oragenics, Inc. (OGEN)
0.9136
-0.02
(-1.84%)
USD |
NYAM |
Dec 12, 16:00
0.8904
-0.02
(-2.54%)
After-Hours: 20:00
Oragenics Research and Development Expense (Annual): 4.114M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |
| Theriva Biologics, Inc. | 12.03M |
| NanoViricides, Inc. | 5.549M |
| Actinium Pharmaceuticals, Inc. | 29.88M |